Test and Usability of Mixed-reality Screening Tool for Early Detection of Cognitive Declines
NCT ID: NCT05403814
Last Updated: 2022-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2022-04-25
2022-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation Study SCOBES-AR
NCT04204239
Spatial Navigation for the Early Detection of Alzheimer's Disease.
NCT06385951
Assessing Cognitive Decline at Home
NCT06704971
Advances in Telephone-based Cognitive Screening Procedures
NCT06337578
Frailty Assessment and Treatment Strategies in the Elderly at Risk of Functional Decline in the Community
NCT03591055
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study aims to establish a protocol for implementation and usability of MR-enhanced multidisciplinary screening tool for early detection of cognitive impairments in the elderly.
In this cross-over design study protocol 100 healthy participants (aged 60-75years) will be screened for cognitive declines using: i) specially developed MST (assessment of cognitive functions, olfactory sensitivity, nutritional preferences, gait parameters, reaction times, activities of daily living, and ii) MR-enhanced MST in which the assessments of cognitive functions, reaction time, activities of daily living and gait are performed using tailor made software and augmented reality and virtual reality hardware. The results of the MR-enhanced MST will be compared with those without MR. The usability of the developed MR-enhanced MST will be tested on 10 investigators and 10 test participants using observed summative evaluation and the co-discovery method and on 2 usability experts using the co-discovery method.
This study was funded by the Austrian Research Promotion Agency and received Ethic Vote from the Ethic committee of the Medical University of Graz. The MR-MST prototype and the study protocol for the present study were developed. To date, no results are available for this study protocol.
The development of the MR-MST prototype enables identifying best practise procedure for evaluating cognitive declines in the elderly using multimodal and MR-enhanced model.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
observational screening procedure (no intervention)
observational screening procedure (no intervention)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Interest in participating in the study
* Signed written informed consent form
Exclusion Criteria
* Clinical diagnosis of mental illness (e.g. depression, psychosis)
* Reduced mobility (walking aid, wheelchair)
* Aided hearing or visual impairment
* Participation in any other cognitive training study within the last 6 months
* Present guardianship according to the provisions of the Austrian adult protection law
60 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
FH Joanneum Gesellschaft mbH
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wolfgang Staubmann, MSc
Role: PRINCIPAL_INVESTIGATOR
FH Joanneum
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
FH-Joanneum
Graz, Styria, Austria
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
Project homepage
Eisenhower's Urgent/Important Principle: Using Time Effectively, Not Just Efficiently
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SCOBES-AR Validation Study 2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.